What is Amdocs Ltd's earnings per share (EPS)?

Amdocs Ltd (DOX) reported diluted earnings per share of $4.25 for fiscal year 2024. This represents a -5.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Amdocs Ltd Financials

DOX

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2024 Currency USD FYE September

This page shows Amdocs Ltd (DOX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 51/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Amdocs Ltd has an operating margin of 12.6%, meaning the company retains $13 of operating profit per $100 of revenue. This results in a moderate score of 50/100, indicating healthy but not exceptional operating efficiency. This is down from 13.4% the prior year.

Growth

Amdocs Ltd's revenue grew a modest 2.4% year-over-year to $5.0B. This slow but positive growth earns a score of 37/100.

Leverage

Amdocs Ltd carries a low D/E ratio of 0.19, meaning only $0.19 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 98/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Amdocs Ltd's current ratio of 1.20 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 19/100, which could limit financial flexibility.

Cash Flow

Amdocs Ltd has a free cash flow margin of 12.4%, earning a moderate score of 56/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Amdocs Ltd's ROE of 14.3% shows moderate profitability relative to equity, earning a score of 43/100. This is down from 15.3% the prior year.

Altman Z-Score Safe

4.15

Amdocs Ltd scores 4.15, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral

5/9

Amdocs Ltd passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.47x

For every $1 of reported earnings, Amdocs Ltd generates $1.47 in operating cash flow ($724.4M OCF vs $493.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

18.0x

Amdocs Ltd earns $18.0 in operating income for every $1 of interest expense ($628.6M vs $34.9M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$5.0B

YoY+2.4%

5Y CAGR+4.1%

10Y CAGR+3.5%

Amdocs Ltd generated $5.0B in revenue in fiscal year 2024. This represents an increase of 2.4% from the prior year.

EBITDA

$819.5M

YoY-2.3%

5Y CAGR+1.1%

10Y CAGR+2.2%

Amdocs Ltd's EBITDA was $819.5M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 2.3% from the prior year.

Net Income

$493.2M

YoY-8.8%

5Y CAGR+0.6%

10Y CAGR+1.6%

Amdocs Ltd reported $493.2M in net income in fiscal year 2024. This represents a decrease of 8.8% from the prior year.

EPS (Diluted)

$4.25

YoY-5.3%

5Y CAGR+4.1%

10Y CAGR+5.0%

Amdocs Ltd earned $4.25 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 5.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$618.9M

YoY-11.4%

10Y CAGR+0.3%

Amdocs Ltd generated $618.9M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 11.4% from the prior year.

Cash & Debt

$346.1M

YoY-33.5%

5Y CAGR-6.0%

10Y CAGR-10.9%

Amdocs Ltd held $346.1M in cash against $646.3M in long-term debt as of fiscal year 2024.

Dividends Per Share

$1.87

YoY+10.1%

5Y CAGR+11.1%

10Y CAGR+12.1%

Amdocs Ltd paid $1.87 per share in dividends in fiscal year 2024. This represents an increase of 10.1% from the prior year.

Shares Outstanding

113M

YoY-3.8%

5Y CAGR-3.5%

10Y CAGR-3.2%

Amdocs Ltd had 113M shares outstanding in fiscal year 2024. This represents a decrease of 3.8% from the prior year.

Margins & Returns

Gross Margin

35.1%

YoY-0.3pp

5Y CAGR-0.0pp

10Y CAGR-0.2pp

Amdocs Ltd's gross margin was 35.1% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 0.3 percentage points from the prior year.

Operating Margin

12.6%

YoY-0.8pp

5Y CAGR-1.4pp

10Y CAGR-1.4pp

Amdocs Ltd's operating margin was 12.6% in fiscal year 2024, reflecting core business profitability. This is down 0.8 percentage points from the prior year.

Net Margin

9.8%

YoY-1.2pp

5Y CAGR-1.9pp

10Y CAGR-2.0pp

Amdocs Ltd's net profit margin was 9.8% in fiscal year 2024, showing the share of revenue converted to profit. This is down 1.2 percentage points from the prior year.

Return on Equity

14.3%

YoY-1.1pp

5Y CAGR+0.6pp

10Y CAGR+1.8pp

Amdocs Ltd's ROE was 14.3% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 1.1 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$563.1M

YoY+15.0%

5Y CAGR+7.2%

10Y CAGR+4.2%

Amdocs Ltd spent $563.1M on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents an increase of 15.0% from the prior year.

Capital Expenditures

$105.5M

YoY-15.2%

10Y CAGR-0.6%

Amdocs Ltd invested $105.5M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 15.2% from the prior year.

DOX Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$5.0B+2.4%	$4.9B+6.8%	$4.6B+6.7%	$4.3B+2.9%	$4.2B+2.0%	$4.1B
Cost of Revenue	$3.2B+2.8%	$3.2B+6.8%	$3.0B+5.2%	$2.8B+2.0%	$2.8B+3.9%	$2.7B
Gross Profit	$1.8B+1.6%	$1.7B+6.7%	$1.6B+9.6%	$1.5B+4.5%	$1.4B-1.4%	$1.4B
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$572.8M+0.4%	$570.7M+8.0%	$528.6M+8.5%	$487.3M+6.3%	$458.5M-6.9%	$492.5M
Operating Income	$628.6M-3.9%	$654.0M-1.6%	$664.8M+11.0%	$598.7M+0.7%	$594.8M+4.4%	$569.7M
Interest Expense	$34.9M+51.1%	$23.1M+36.6%	$16.9M-20.5%	$21.3M+104.0%	$10.4M+166.6%	$3.9M
Income Tax	$94.8M+1.4%	$93.4M-5.6%	$98.9M-21.5%	$125.9M+47.3%	$85.5M-3.3%	$88.4M
Net Income	$493.2M-8.8%	$540.7M-1.6%	$549.5M-20.2%	$688.4M+38.3%	$497.8M+3.8%	$479.4M
EPS (Diluted)	$4.25-5.3%	$4.49+1.1%	$4.44-16.5%	$5.32+43.4%	$3.71+6.9%	$3.47

Metric	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23
Revenue	$1.3B+1.1%	$1.3B+0.3%	$1.2B+0.1%	$1.2B+0.2%	$1.2B+0.5%	$1.2B+1.0%	$1.2B+3.2%	$1.2B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	$112.7M-35.9%	$175.9M+12.9%	$155.7M-15.5%	$184.3M+32.7%	$138.9M-24.0%	$182.7M+0.2%	$182.3M+21.5%	$150.1M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	$86.4M-38.4%	$140.3M+18.4%	$118.5M-19.9%	$148.0M+45.0%	$102.0M-36.0%	$159.4M+6.6%	$149.6M+15.4%	$129.7M
EPS (Diluted)	$0.76-37.2%	$1.21+19.8%	$1.01-19.8%	$1.26+46.5%	$0.86-34.8%	$1.32+7.3%	$1.23+15.0%	$1.07

DOX Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$6.4B-0.6%	$6.4B+0.6%	$6.4B-1.9%	$6.5B+2.7%	$6.3B+19.8%	$5.3B
Current Assets	$1.8B-7.3%	$1.9B-4.6%	$2.0B-3.1%	$2.1B-0.3%	$2.1B+23.8%	$1.7B
Cash & Equivalents	$346.1M-33.5%	$520.1M-9.3%	$573.4M-19.1%	$709.1M-27.9%	$983.2M+108.5%	$471.6M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$1.0B+8.9%	$944.5M-0.2%	$946.8M+9.2%	$866.8M+0.7%	$861.0M-12.8%	$987.9M
Goodwill	$2.8B+3.5%	$2.7B+3.2%	$2.7B+1.5%	$2.6B+1.7%	$2.6B+4.7%	$2.5B
Total Liabilities	$2.9B+1.0%	$2.9B+1.0%	$2.8B-1.6%	$2.9B+7.5%	$2.7B+52.9%	$1.8B
Current Liabilities	$1.5B+8.7%	$1.4B+8.0%	$1.3B-3.9%	$1.3B+7.2%	$1.2B+0.7%	$1.2B
Long-Term Debt	$646.3M+0.1%	$645.7M+0.1%	$645.1M+0.1%	$644.6M+0.1%	$644.0M	N/A
Total Equity	$3.5B-1.9%	$3.5B+0.2%	$3.5B-2.1%	$3.6B-0.8%	$3.6B+3.5%	$3.5B
Retained Earnings	$6.8B+4.2%	$6.5B+5.4%	$6.2B+6.2%	$5.9B+9.5%	$5.3B+6.6%	$5.0B

Metric	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23
Total Assets	$6.4B	N/A	N/A	N/A	$6.4B	N/A	N/A	N/A
Current Assets	$1.8B	N/A	N/A	N/A	$1.9B	N/A	N/A	N/A
Cash & Equivalents	$346.1M	N/A	N/A	N/A	$520.1M	N/A	N/A	N/A
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$1.0B	N/A	N/A	N/A	$944.5M	N/A	N/A	N/A
Goodwill	$2.8B	N/A	N/A	N/A	$2.7B	N/A	N/A	N/A
Total Liabilities	$2.9B	N/A	N/A	N/A	$2.9B	N/A	N/A	N/A
Current Liabilities	$1.5B	N/A	N/A	N/A	$1.4B	N/A	N/A	N/A
Long-Term Debt	$646.3M	N/A	N/A	N/A	$645.7M	N/A	N/A	N/A
Total Equity	$3.5B	N/A	N/A	N/A	$3.5B	N/A	N/A	N/A
Retained Earnings	$6.8B	N/A	N/A	N/A	$6.5B	N/A	N/A	N/A

DOX Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$724.4M-11.9%	$822.6M+8.7%	$756.7M-18.3%	$925.8M+40.7%	$658.1M+0.3%	$656.4M
Capital Expenditures	$105.5M-15.2%	$124.4M-45.3%	$227.2M+8.0%	$210.4M	N/A	N/A
Free Cash Flow	$618.9M-11.4%	$698.3M+31.9%	$529.5M-26.0%	$715.4M	N/A	N/A
Investing Cash Flow	-$127.4M+43.2%	-$224.5M+14.5%	-$262.5M+20.2%	-$329.0M+28.7%	-$461.7M-432.2%	-$86.8M
Financing Cash Flow	-$771.0M-18.4%	-$651.4M-3.4%	-$629.9M+27.7%	-$870.9M-376.4%	$315.1M+161.0%	-$516.8M
Dividends Paid	$212.0M+6.3%	$199.5M+7.2%	$186.1M+4.8%	$177.5M+8.2%	$164.1M+11.1%	$147.6M
Share Buybacks	$563.1M+15.0%	$489.5M-3.7%	$508.5M-25.2%	$680.0M+88.4%	$360.9M-9.3%	$398.1M

Metric	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23
Operating Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

DOX Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	35.1%-0.3pp	35.4%-0.0pp	35.4%+0.9pp	34.5%+0.6pp	33.9%-1.2pp	35.1%
Operating Margin	12.6%-0.8pp	13.4%-1.2pp	14.5%+0.6pp	14.0%-0.3pp	14.3%+0.3pp	13.9%
Net Margin	9.8%-1.2pp	11.1%-0.9pp	12.0%-4.0pp	16.1%+4.1pp	11.9%+0.2pp	11.7%
Return on Equity	14.3%-1.1pp	15.3%-0.3pp	15.6%-3.5pp	19.2%+5.4pp	13.7%+0.0pp	13.7%
Return on Assets	7.7%-0.7pp	8.4%-0.2pp	8.6%-2.0pp	10.6%+2.7pp	7.8%-1.2pp	9.1%
Current Ratio	1.20-0.2	1.41-0.2	1.60+0.0	1.59-0.1	1.71+0.3	1.39
Debt-to-Equity	0.190.0	0.180.0	0.180.0	0.180.0	0.18-0.3	0.50
FCF Margin	12.4%-1.9pp	14.3%+2.7pp	11.6%-5.1pp	16.7%	N/A	N/A

Metric	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	8.9%-5.2pp	14.1%+1.6pp	12.5%-2.3pp	14.8%+3.6pp	11.2%-3.6pp	14.8%-0.1pp	14.9%+2.2pp	12.7%
Net Margin	6.8%-4.4pp	11.2%+1.7pp	9.5%-2.4pp	11.9%+3.7pp	8.2%-4.7pp	12.9%+0.7pp	12.2%+1.3pp	10.9%
Return on Equity	2.5%	N/A	N/A	N/A	2.9%	N/A	N/A	N/A
Return on Assets	1.4%	N/A	N/A	N/A	1.6%	N/A	N/A	N/A
Current Ratio	1.20	N/A	N/A	N/A	1.41	N/A	N/A	N/A
Debt-to-Equity	0.19	N/A	N/A	N/A	0.18	N/A	N/A	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

$5.8B

$4.8B

$5.5B

$3.8B

$7.6B

Frequently Asked Questions

What is Amdocs Ltd's annual revenue?

Amdocs Ltd (DOX) reported $5.0B in total revenue for fiscal year 2024. This represents a 2.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Amdocs Ltd's revenue growing?

Amdocs Ltd (DOX) revenue grew by 2.4% year-over-year, from $4.9B to $5.0B in fiscal year 2024.

Is Amdocs Ltd profitable?

Yes, Amdocs Ltd (DOX) reported a net income of $493.2M in fiscal year 2024, with a net profit margin of 9.8%.

What is Amdocs Ltd's EBITDA?

Amdocs Ltd (DOX) had EBITDA of $819.5M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Amdocs Ltd have?

As of fiscal year 2024, Amdocs Ltd (DOX) had $346.1M in cash and equivalents against $646.3M in long-term debt.

What is Amdocs Ltd's gross margin?

Amdocs Ltd (DOX) had a gross margin of 35.1% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Amdocs Ltd's operating margin?

Amdocs Ltd (DOX) had an operating margin of 12.6% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Amdocs Ltd's net profit margin?

Amdocs Ltd (DOX) had a net profit margin of 9.8% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Does Amdocs Ltd pay dividends?

Yes, Amdocs Ltd (DOX) paid $1.87 per share in dividends during fiscal year 2024.

What is Amdocs Ltd's return on equity (ROE)?

Amdocs Ltd (DOX) has a return on equity of 14.3% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Amdocs Ltd's free cash flow?

Amdocs Ltd (DOX) generated $618.9M in free cash flow during fiscal year 2024. This represents a -11.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Amdocs Ltd's operating cash flow?

Amdocs Ltd (DOX) generated $724.4M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Amdocs Ltd's total assets?

Amdocs Ltd (DOX) had $6.4B in total assets as of fiscal year 2024, including both current and long-term assets.

What are Amdocs Ltd's capital expenditures?

Amdocs Ltd (DOX) invested $105.5M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

Does Amdocs Ltd buy back shares?

Yes, Amdocs Ltd (DOX) spent $563.1M on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.

How many shares does Amdocs Ltd have outstanding?

Amdocs Ltd (DOX) had 113M shares outstanding as of fiscal year 2024.

What is Amdocs Ltd's current ratio?

Amdocs Ltd (DOX) had a current ratio of 1.20 as of fiscal year 2024, which is considered adequate.

What is Amdocs Ltd's debt-to-equity ratio?

Amdocs Ltd (DOX) had a debt-to-equity ratio of 0.19 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Amdocs Ltd's return on assets (ROA)?

Amdocs Ltd (DOX) had a return on assets of 7.7% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Amdocs Ltd's Altman Z-Score?

Amdocs Ltd (DOX) has an Altman Z-Score of 4.15, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Amdocs Ltd's Piotroski F-Score?

Amdocs Ltd (DOX) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Amdocs Ltd's earnings high quality?

Amdocs Ltd (DOX) has an earnings quality ratio of 1.47x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Amdocs Ltd cover its interest payments?

Amdocs Ltd (DOX) has an interest coverage ratio of 18.0x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Amdocs Ltd?

Amdocs Ltd (DOX) scores 51 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.